The new antibiotic reception scheme reduces the risks of resistance

0
3
views

It turned out that the new combined treatment protocol with antibiotics reduces the stability of pathogens, and does not provoke it, as previously thought. This discovery is of very important global importance, since continuously growing resistance to antibacterial drugs is considered one of the main threats to the health of the world’s population.

Resistance to antibacterial drugs is due to their uncontrolled and frequent reception. For a long time it was believed that the joint use of antibiotics leads to cross-stability, but the new work of German studies demonstrates the opposite. Conclusions of research

«Now we are in a crisis situation, when excessive use of antibiotics leads to an increase in resistance, so some infections have become difficult or even impossible to treat,» said the collaborator of the Aditi Batra.

The nature of the development of sustainability is due to the ability of pathogens to adapt to drugs.

Scientists tested three different sequences of taking antibiotics for bacteria, causing pneumonia and other infections from humans.

The results of experiments were very unexpected. Treatment with antibiotics from one class has better cope with infection than the use of unrelated preparations. In addition, the rapid switching from one drug to another led to a better result than with a more slow therapy scheme.

This new understanding will allow to evaluate the indicators of spontaneous resistance of antibiotic components and use them as guidelines for creating consecutive protocols, increasing the effectiveness of treatment and reducing the risks of sustainability, the authors concluded.

Previously, scientists presented other disappointing conclusions about the consequences of abuse of antibiotics. They found that the risks of development of intestinal cancer


We tell about the most interesting news and technologies — from the upcoming total automation to alternative energy, from artificial intelligence to the future medicine.

Hayk +